Assessment of the hepatoprotective effects of Bicyclol's forced degradation products using a zebrafish model
Journal of Pharmaceutical and Biomedical Analysis · 2025
DOI: 10.1016/j.jpba.2025.116871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2025. Verfasst von Mengqi Jia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, PR China. Hauptthemen laut MEDLINE: Biphenyl Compounds, Liver, Protective Agents, Fatty Liver, Alcoholic. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Shanghai Jiao Tong University, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Bicyclol (BIC), a synthetic hepatoprotective agent widely prescribed in China, lacks comprehensive safety and activity profiles for its degradation products (DPs). Here, we systematically investigated BIC's forced degradation behavior using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS). Three hydrolytic degradation products (DP1-DP3) were isolated via HPLC and structurally characterized, revealing methylenedioxy group hydrolysis as the primary degradation pathway. Molecular docking simulations demonstrated enhanced target binding affinities of DPs compared to BIC, supported by absorption, distribution, metabolism, and excretion (ADME) predictions showing improved drug-likeness. In an alcohol-induced fatty liver zebrafish model, both BIC and its DPs attenuated hepatic macrovesicular steatosis and inflammatory responses. Mechanistically, treatment normalized lipid metabolism by downregulating alcohol-induced expression of FASN, SREBP1, PPARα, and PPARγ, while reduced IL-6 and TNF-α levels confirmed anti-inflammatory efficacy. These findings demonstrate that BIC DPs exhibit dual pharmacological activity through lipid homeostasis modulation and inflammation suppression, providing critical insights for quality control and therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, PR China.
- School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, PR China.
- School of Medicine, Shanghai University, Shanghai 200444, PR China.
- School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, PR China. Electronic address: lilijing@sjtu.edu.cn.
- Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, PR China; School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, PR China. Elec…
Förderung
- Shanghai Jiao Tong University
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Jia, M., Yang, R., Ma, C., Gu, C., Wu, D., Huang, X., Jing, L., & Fan, G. (2025). Assessment of the hepatoprotective effects of Bicyclol's forced degradation products using a zebrafish model. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2025.116871
Vancouver
Jia M, Yang R, Ma C, Gu C, Wu D, Huang X, et al. Assessment of the hepatoprotective effects of Bicyclol's forced degradation products using a zebrafish model. Journal of Pharmaceutical and Biomedical Analysis. 2025. doi:10.1016/j.jpba.2025.116871
BibTeX
@article{Jia2025,
author = {Jia, Mengqi and Yang, Runjuan and Ma, Cui and Gu, Chao and Wu, Dongying and Huang, Xucong and Jing, Lili and Fan, Guorong},
title = {Assessment of the hepatoprotective effects of Bicyclol's forced degradation products using a zebrafish model},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2025},
doi = {10.1016/j.jpba.2025.116871}
}
EUVIMED